Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
2.
Int Nurs Rev ; 65(3): 327-335, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29424421

ABSTRACT

AIM: To examine the perceptions of nurse managers, registered nurses and healthcare assistants of physical restraint use on older people in a long-term care setting in the Republic of Ireland. BACKGROUND: The use of physical restraint, although controversial, persists in long-term care settings, despite recommendations for restraint-free environments. Perception and attitude of staff can influence use of physical restraint. METHODS: A descriptive cross-sectional design was used. A total of 250 nursing and healthcare assistant staff were recruited. A questionnaire incorporating demographics and the Perceptions of Restraint Use Questionnaire was used. Descriptive and inferential statistical analyses were conducted. RESULTS: Mean age of respondents (n = 156) was 41 years, and the majority were female. Overall, a low level of importance was attached to the use of restraint. Nurse managers and registered nurses compared favourably with healthcare assistants who attached a higher importance to use of restraint. Across all three staff groups, greatest importance was attached to the use of physical restraint for reducing falls, followed by prevention of treatment interference. Restraint was least favoured as a means of impairment management. Education was not an explanatory factor in perceived importance of physical restraint use. CONCLUSION: Nurse managers and registered nurses are unlikely to use physical restraint. However, there is concern regarding perception of healthcare assistants on use of restraint. IMPLICATIONS FOR NURSING AND HEALTH POLICY: Results from this study compare favourably with those in countries that have no policy on physical restraint use. Educational programmes alone are insufficient to address use of physical restraint. Attention to skill mix with adequate support for healthcare assistants in long-term care settings is recommended.


Subject(s)
Allied Health Personnel/psychology , Attitude of Health Personnel , Long-Term Care/methods , Nurse Administrators/psychology , Nursing Staff, Hospital/psychology , Restraint, Physical/psychology , Adult , Cross-Sectional Studies , Female , Humans , Ireland , Male , Middle Aged , Nursing Homes , Surveys and Questionnaires
3.
Foot Ankle Surg ; 24(3): 252-258, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29409250

ABSTRACT

BACKGROUND: Hallux valgus is a common condition with in excess of 120 procedures described in the literature for its correction. Traditionally, distal metatarsal osteotomies have been employed in the treatment of mild deformities, with proximal osteotomies being reserved for more severe presentations. The Scarf osteotomy without internal fixation allows large translations which can successfully correct severe hallux valgus deformities, without limitations related to screw placement. METHODS: This is a retrospective single surgeon case series performed over a three year period. One hundred and forty-eight cases were identified, with an average follow up time of 16.5 months. Visual analogue scales were used to obtain preoperative and postoperative pain and cosmetic scores, with the Foot and Ankle Disability Index (FADI) index used to assess functional status. The hallux valgus angle (HVA) and intermetatarsal angle (IMA) were assessed on preoperative and postoperative AP weight-bearing foot X-rays. RESULTS: The mean pain score improved from 7.04/10 preoperatively to 0.29/10 postoperatively. The mean cosmetic score improved from 2.1/10 to 9.1/10 postoperatively. The mean preoperative HVA and IMA were 35.04° and 15.04°, respectively. The mean postoperative HVA and IMA were 11.54° and 4.83°, respectively. The mean postoperative FADI score was 103.4/104. We report a loss of correction in two cases. One revision surgery was performed. CONCLUSIONS: We report a large series of cases of the modified Scarf osteotomy as described by Maestro-a versatile, cost-effective, safe and reliable technique with the potential for three dimensional correction. Whilst this is a technically demanding procedure, we recommend the use of the modified Scarf osteotomy in the treatment of a wide range of hallux valgus deformities.


Subject(s)
Hallux Valgus/surgery , Metatarsal Bones/surgery , Osteotomy/methods , Radiography/methods , Weight-Bearing/physiology , Adolescent , Adult , Aged , Female , Hallux Valgus/diagnosis , Hallux Valgus/physiopathology , Humans , Internal Fixators , Male , Metatarsal Bones/diagnostic imaging , Middle Aged , Retrospective Studies , Treatment Outcome , Young Adult
4.
J Orthop ; 14(2): 231-235, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28203049

ABSTRACT

INTRODUCTION: Both ASR hip resurfacings and stemmed ASR XL arthroplasties have failed at high rates in several published series. We assessed a single surgeon series of these arthroplasties looking to identify factors associated with their failure. METHODS: All surgeries were performed by one surgeon. Patients were evaluated clinically, radiologically and with serial cobalt and chromium ion analysis. RESULTS: 274 implants were analysed - 152 ASR resurfacings and 122 ASR XL implants. Thirty revisions were performed. CONCLUSION: The failure rate of the ASR implant in our series is unacceptably high - its use in routine hip arthroplasty cannot be supported.

5.
Ir J Med Sci ; 186(3): 683-686, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28161738

ABSTRACT

INTRODUCTION: Traditionally orthopaedic injections were performed in a theatre setting. A dedicated outpatient injection clinic was established at our institution to attempt to provide injections more cost effectively. Our aim was to perform a cost analysis of orthopaedic injections performed in theatre, compared to those performed in a dedicated OPD injection clinic. METHODS: Patient data for all orthopaedic injections performed at a single institution from 2013 to 2014 was obtained using HIPE data. A detailed breakdown of costings for two scenarios; those performed in theatre and those in the dedicated OPD injection clinic was obtained from the hospital finance department. A unit cost per injection for theatre and OPD was derived from this financial information. RESULTS: A total of 487 injections were performed in 2013, with 491 performed in 2014. 134 (27.5%) injections were performed in the OPD in 2013 compared to 388 (79%) in 2014. The unit cost per injection was calculated as €52.13 for theatre and €23.85 for OPD, this represented a 115% decrease in cost per injection. CONCLUSION: The creation of a dedicated orthopaedic injection clinic resulted in considerable cost savings at our institution. We propose this may be a more cost-efficient model for delivery of injections in the orthopaedic setting.


Subject(s)
Costs and Cost Analysis/methods , Orthopedics/economics , Ambulatory Care Facilities , Humans , Injections , Outpatients
6.
J Orthop ; 14(1): 34-37, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27821999

ABSTRACT

INTRODUCTION: Achieving skeletal fixation in the presence of progressive bone loss is a surgical challenge, especially in cases of periprosthetic fracture (PPF). Unpredictable fracture patterns and preexisting bone loss frequently combine in this patient group. Megaprosthetic arthroplasty allows for immediate mobilisation and shorter periods of rehabilitation. We describe the clinical outcomes of a cohort of LPS™ megaprostheses performed for PPF by a single surgeon at our institution. METHODS: Between July 2013 and November 2015, 23 patients underwent endoprosthetic femoral replacement of which 16 were performed for PPF or bone loss. Patient demographics, surgical indication, operative details, implant composition, blood loss, survival, and revision surgery details were recorded in a prospectively maintained database. Patients underwent serial clinical and X-ray evaluations at 6 weeks, 3 months and 6 months post surgery with yearly reviews thereafter. RESULTS: The PPF cohort consisted of 9 males and 7 females with a mean age of 75 and a mean follow up of 19.2 months. The mean Oxford score prior to fracture was 41 (range 12-48), and 39 (range 13-48, p = 0.6) post megaprosthesis insertion. Postoperative dislocation of the megaprosthesis occurred in two patients (12.5%), with no postoperative infections recorded. CONCLUSION: We report minimal postoperative changes in functional outcome scores. The results of revision arthroplasty with LPS™ proximal femur megaprosthesis were satisfactory in 15/16 patients at a mean follow-up of 19.2 months. We recommend the use of megaprostheses in patients with markedly deficient bone stock for whom other available reconstructive procedures are unavailable.

7.
Cell Death Dis ; 7: e2220, 2016 05 12.
Article in English | MEDLINE | ID: mdl-27171262

ABSTRACT

Expansive growth of neural progenitor cells (NPCs) is a prerequisite to the temporal waves of neuronal differentiation that generate the six-layered neocortex, while also placing a heavy burden on proteins that regulate chromatin packaging and genome integrity. This problem is further reflected by the growing number of developmental disorders caused by mutations in chromatin regulators. ATRX gene mutations cause a severe intellectual disability disorder (α-thalassemia mental retardation X-linked (ATRX) syndrome; OMIM no. 301040), characterized by microcephaly, urogenital abnormalities and α-thalassemia. Although the ATRX protein is required for the maintenance of repetitive DNA within heterochromatin, how this translates to disease pathogenesis remain poorly understood and was a focus of this study. We demonstrate that Atrx(FoxG1Cre) forebrain-specific conditional knockout mice display poly(ADP-ribose) polymerase-1 (Parp-1) hyperactivation during neurogenesis and generate fewer late-born Cux1- and Brn2-positive neurons that accounts for the reduced cortical size. Moreover, DNA damage, induced Parp-1 and Atm activation is elevated in progenitor cells and contributes to their increased level of cell death. ATRX-null HeLa cells are similarly sensitive to hydroxyurea-induced replication stress, accumulate DNA damage and proliferate poorly. Impaired BRCA1-RAD51 colocalization and PARP-1 hyperactivation indicated that stalled replication forks are not efficiently protected. DNA fiber assays confirmed that MRE11 degradation of stalled replication forks was rampant in the absence of ATRX or DAXX. Indeed, fork degradation in ATRX-null cells could be attenuated by treatment with the MRE11 inhibitor mirin, or exacerbated by inhibiting PARP-1 activity. Taken together, these results suggest that ATRX is required to limit replication stress during cellular proliferation, whereas upregulation of PARP-1 activity functions as a compensatory mechanism to protect stalled forks, limiting genomic damage, and facilitating late-born neuron production.


Subject(s)
DNA Helicases/genetics , DNA Replication , Heterochromatin/chemistry , Neurons/metabolism , Nuclear Proteins/genetics , Poly (ADP-Ribose) Polymerase-1/genetics , Animals , Ataxia Telangiectasia Mutated Proteins/genetics , Ataxia Telangiectasia Mutated Proteins/metabolism , BRCA1 Protein , Carrier Proteins/genetics , Cell Proliferation/drug effects , Co-Repressor Proteins , DNA/genetics , DNA/metabolism , DNA Damage , DNA Helicases/deficiency , DNA Repair Enzymes/genetics , DNA Repair Enzymes/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Gene Expression Regulation , HeLa Cells , Heterochromatin/drug effects , Heterochromatin/metabolism , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , Hydroxyurea/pharmacology , Intracellular Signaling Peptides and Proteins/deficiency , Intracellular Signaling Peptides and Proteins/genetics , MRE11 Homologue Protein , Mice , Mice, Knockout , Molecular Chaperones , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurogenesis/genetics , Neurons/cytology , Neurons/drug effects , Nuclear Proteins/deficiency , Nuclear Proteins/metabolism , POU Domain Factors/genetics , POU Domain Factors/metabolism , Poly (ADP-Ribose) Polymerase-1/metabolism , Prosencephalon/cytology , Prosencephalon/drug effects , Prosencephalon/metabolism , Rad51 Recombinase/genetics , Rad51 Recombinase/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolism , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism , X-linked Nuclear Protein
8.
Ir Med J ; 108(1): 21-2, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25702350

ABSTRACT

Single stage en bloc abdominoperineal resection and sacrectomy, with a myocutaneous flap closure is a relatively uncommon procedure. Our case study of a 77 year old man with a locally invasive rectal adenocarcinoma highlights the complex intraoperative management of such a patient.


Subject(s)
Digestive System Surgical Procedures/methods , Rectal Neoplasms , Sacrum , Spinal Neoplasms , Aged , Colectomy , Humans , Male , Osteotomy , Rectal Neoplasms/pathology , Rectal Neoplasms/surgery , Sacrum/pathology , Sacrum/surgery , Spinal Neoplasms/pathology , Spinal Neoplasms/surgery , Surgical Flaps
9.
Biochem Biophys Res Commun ; 325(3): 683-90, 2004 Dec 17.
Article in English | MEDLINE | ID: mdl-15541343

ABSTRACT

Histone deacetylase (HDAC) inhibitors induce the hyperacetylation of nucleosomal histones in carcinoma cells resulting in the expression of repressed genes that cause growth arrest, terminal differentiation, and/or apoptosis. In vitro selectivity of several novel hydroxamate HDAC inhibitors including succinimide macrocyclic hydroxamates and the non-hydroxamate alpha-ketoamide inhibitors was investigated using isolated enzyme preparations and cellular assays. In vitro selectivity for the HDAC isozymes (HDAC1/2, 3, 4/3, and 6) was not observed for these HDAC inhibitors or the reference HDAC inhibitors, MS-275 and SAHA. In T24 and HCT116 cells these compounds caused the accumulation of acetylated histones H3 and H4; however, the succinimide macrocyclic hydroxamates and the alpha-ketoamides did not cause the accumulation of acetylated alpha-tubulin. These data suggest "selectivity" can be observed at the cellular level with HDAC inhibitors and that the nature of the zinc-chelating moiety is an important determinant of activity against tubulin deacetylase.


Subject(s)
Amides/pharmacology , Breast Neoplasms/enzymology , Fibrosarcoma/enzymology , Histone Deacetylase Inhibitors , Histone Deacetylases/metabolism , Hydroxamic Acids/pharmacology , Amides/chemistry , Breast Neoplasms/pathology , Cell Line, Tumor , Cell Proliferation/drug effects , Enzyme Activation/drug effects , Enzyme Inhibitors , Fibrosarcoma/pathology , Histone Deacetylases/chemistry , Humans , Hydroxamic Acids/chemistry
10.
Ir J Med Sci ; 173(4): 191-2, 2004.
Article in English | MEDLINE | ID: mdl-16323611

ABSTRACT

BACKGROUND: During adolescence, people tend to begin drinking alcohol and become involved in the culture that surrounds it. AIM: To compare the influence of peer relationships among females in mixed-sex schools versus single-sex schools on cigarette smoking and alcohol consumption. METHODS: A cross-sectional study was carried out in four schools. The information was collected by means of a questionnaire. RESULTS: Two hundred and forty-eight questionnaires were completed. Of those questioned in single-sex schools, 34% had smoked a cigarette compared with 61% in mixed-sex schools (p < 0.005). The lifetime prevalence of alcohol consumption in mixed-sex schools was 88% compared with 73% in single-sex schools (p < 0.005). CONCLUSION: This study suggests that females in mixed-sex schools have a tendency to have earlier exposure to smoking and alcohol consumption than girls of the same age in single-sex schools.


Subject(s)
Adolescent Behavior , Alcohol Drinking/psychology , Peer Group , Smoking/psychology , Adolescent , Alcohol Drinking/epidemiology , Cross-Sectional Studies , Female , Humans , Ireland/epidemiology , Male , Prevalence , Risk Factors , Schools/organization & administration , Smoking/epidemiology , Surveys and Questionnaires
11.
Acupunct Med ; 19(1): 69-70, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11471594

ABSTRACT

Following his attendance at the ICMART meeting, in Myasaki in 1988, the author, a BMAS member, resolved to revisit Japan. He found that acupuncture was widely practised throughout the country; although the patients were in the main elderly. The range of techniques used ranged from TCM to western, and broadly mirrored the styles practised in the West. Most young people in Japan considered acupuncture to be rather old fashioned, and it is postulated that this contrasts with the population seeking complementary medicine in the West.


Subject(s)
Acupuncture Therapy , Anecdotes as Topic , Congresses as Topic , Humans , Japan , Travel
12.
Bioorg Med Chem Lett ; 11(12): 1553-6, 2001 Jun 18.
Article in English | MEDLINE | ID: mdl-11412979

ABSTRACT

A novel series of biaryl ether reverse hydroxamate MMP inhibitors has been developed. These compounds are potent MMP-2 inhibitors with limited activity against MMP-1. Select members of this series exhibit excellent pharmacokinetic properties with long elimination half-lives (7 h) and high oral bioavailability (100%).


Subject(s)
Hydroxamic Acids/chemical synthesis , Matrix Metalloproteinase Inhibitors , Administration, Oral , Animals , Antineoplastic Agents/blood , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacokinetics , Biological Availability , Enzyme Inhibitors/blood , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacokinetics , Half-Life , Hydroxamic Acids/chemistry , Inhibitory Concentration 50 , Injections, Intravenous , Macaca fascicularis
13.
Bioorg Med Chem Lett ; 11(12): 1557-60, 2001 Jun 18.
Article in English | MEDLINE | ID: mdl-11412980

ABSTRACT

Modification of the biphenyl portion of MMP inhibitor 2a gave analogue 2i which is greater than 1000-fold selective against MMP-2 versus MMP-1. The stereospecific synthesis of both enantiomers of 2i was achieved beginning with (S)- or (R)-benzyl glycidyl ether. The (S)-enantiomer, 11 (ABT-770), is orally bioavailable and efficacious in an in vivo model of tumor growth.


Subject(s)
Biphenyl Compounds/pharmacokinetics , Hydroxamic Acids/pharmacokinetics , Matrix Metalloproteinase Inhibitors , Administration, Oral , Animals , Antineoplastic Agents/blood , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacokinetics , Area Under Curve , Biological Availability , Biphenyl Compounds/blood , Biphenyl Compounds/chemical synthesis , Cell Division/drug effects , Dogs , Enzyme Inhibitors/blood , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacokinetics , Half-Life , Haplorhini , Hydroxamic Acids/blood , Hydroxamic Acids/chemical synthesis , Inhibitory Concentration 50 , Injections, Intravenous , Metabolic Clearance Rate , Neoplasms, Experimental/drug therapy , Rats , Structure-Activity Relationship , Tumor Cells, Cultured
14.
Spine (Phila Pa 1976) ; 25(18): 2355-7, 2000 Sep 15.
Article in English | MEDLINE | ID: mdl-10984788

ABSTRACT

STUDY DESIGN: Epidural infusion was compared with standard patient-controlled analgesia (PCA) in 50 patients after surgical correction of adolescent idiopathic scoliosis with respect to certain postoperative parameters. OBJECTIVES: To compare postoperative parameters after posterior spinal instrumentation and fusion (PSIF) and to determine whether epidural infusion prolongs hospital stay or increases the risk of complications. SUMMARY OF BACKGROUND DATA: Patient-controlled analgesia and epidural infusion are both safe and effective in controlling postoperative pain after PSIF. One criticism of epidural infusion has been longer hospital stays. No study was found in the literature in which PCA was compared with epidural infusion. METHODS: The records of 50 consecutive patients who had undergone PSIF were reviewed. The epidural group consisted of 30 patients and the PCA group 20. Age, weight, degree of curve, and levels fused were evenly matched. Postoperative parameters including the day that each patient tolerated a full diet, day of independent ambulation, length of hospital stay, and pain control were compared. RESULTS: Pain control was comparable in each group. The epidural group tolerated a full diet earlier and on average were discharged 0.5 days sooner than the PCA group. Both differences are statistically significant. No significant complications were reported in either group. CONCLUSIONS: Epidural infusion of opioids with bupivacaine is safe and effective for controlling postoperative pain after PSIF without an increased complication rate when compared with PCA. In the current study, patients tolerated a full diet and were discharged from the hospital an average of 0.5 days earlier than PCA-treated patients.


Subject(s)
Analgesia, Epidural , Analgesia, Patient-Controlled , Analgesics, Opioid/administration & dosage , Infusion Pumps , Pain, Postoperative/drug therapy , Scoliosis/surgery , Adolescent , Analgesia, Epidural/methods , Analgesia, Patient-Controlled/methods , Anesthetics, Local/therapeutic use , Bupivacaine/therapeutic use , Drug Combinations , Female , Humans , Male , Retrospective Studies , Self Administration , Spinal Fusion
15.
J Enzyme Inhib ; 14(6): 425-35, 1999.
Article in English | MEDLINE | ID: mdl-10536876

ABSTRACT

Two series of compounds synthesized as specific matrix metalloproteinase (MMP) inhibitors have been evaluated for their inhibition of non-MMPs. In a series of substituted succinyl hydroxamic acids, some were found to be significant (IC50 < 1 microM) inhibitors of leucine (microsomal) aminopeptidase, neprilysin (3.4.24.11), and thermolysin. Macrocyclic compounds in which the alpha carbon of the succinyl hydroxamate is linked to the side chain of the P2' amino acid were found to be good inhibitors of aminopeptidase, but not of neprilysin or thermolysin. Compounds of neither series were found to be significant inhibitors of angiotensin converting enzyme or carboxypeptidase A.


Subject(s)
Matrix Metalloproteinase Inhibitors , Metalloendopeptidases/antagonists & inhibitors , Angiotensin-Converting Enzyme Inhibitors , Animals , Bacterial Proteins , Carboxypeptidases/antagonists & inhibitors , Carboxypeptidases A , Cattle , Hydroxamic Acids/chemical synthesis , Hydroxamic Acids/metabolism , Inhibitory Concentration 50 , Leucyl Aminopeptidase/antagonists & inhibitors , Neprilysin/antagonists & inhibitors , Protease Inhibitors/chemical synthesis , Protease Inhibitors/chemistry , Protease Inhibitors/metabolism , Rabbits , Rats , Swine , Thermolysin/antagonists & inhibitors , Zinc/metabolism
16.
Curr Pharm Des ; 5(10): 787-819, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10529436

ABSTRACT

Excess MMP proteolytic activity has been associated with a wide variety of pathological conditions such as arthritis, cancer and heart failure. The potential utility of MMP inhibitors as therapeutic interventions in these diverse and important disease states has led to an intense effort toward the development of such inhibitors. The first generation of compounds were peptide-like broad spectrum inhibitors, active against a broad range of MMPs. However, the induction of musculoskeletal side effects seen in clinical trials with these agents has emphasized the need for a better understanding of the role that each of the MMPs plays in normal tissue turnover and disease progression. Advances in our ability to engineer and synthesize selective inhibitors as well as the discovery of small molecule, non-peptidic inhibitors has spurred an intense effort to identify potent and bioavailable second generation compounds. There are now several such compounds targeted against various subsets of the MMPs in clinical development. This review will focus on the design and structure activity relationships of these second generation compounds.


Subject(s)
Enzyme Inhibitors/therapeutic use , Matrix Metalloproteinase Inhibitors , Metalloproteins/physiology , Peptides/pharmacology , Succinates/pharmacology , Clinical Trials as Topic , Humans , Structure-Activity Relationship
17.
J Pharmacol Exp Ther ; 284(1): 83-8, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9435164

ABSTRACT

Platelet-activating factor (PAF) may be an important mediator of allergic rhinitis. In the present study we evaluated the effectiveness of a recently described PAF antagonist (ABT-491) in rat and guinea pig models of allergic rhinitis. PAF, when perfused through the nasal passages of anesthetized Brown Norway rats, provoked an acute increase, measured as dye leakage, in nasal vascular permeability evident within 15 min after exposure to PAF. ABT-491, given orally 1 hr before PAF challenge, inhibited the response in a dose-related manner (ED50 = 0.3 mg/kg). Intranasal perfusion with ovalbumin in rats sensitized to the antigen 18 to 21 days before challenge also induced an increase in vascular permeability. The antigen-induced leakage was inhibited a maximum of 74% (P < or = .001) by pretreatment with ABT-491 (3 mg/kg p.o.). An antihistamine (mepyramine, 10 mg/kg i.p.), a serotonin antagonist (methysergide) and a 5-lipoxygenase inhibitor (A-79175) also exhibited efficacy in this model (56%, 87% and 65% inhibition, respectively). Nearly complete inhibition (93%, P < or = .001) of the response was achieved by coadministration of ABT-491 and methysergide. In guinea pigs intranasal administration of PAF resulted in increased airway resistance that was inhibited in a dose-dependent manner by oral administration of ABT-491 (ED50 = 1 mg/kg). Antigen-induced nasal airway resistance, triggered by exposure of sensitized animals to aerosolized ovalbumin, was also inhibited by ABT-491 (maximum inhibition 64%, P < or = .05, 10 mg/kg p.o.). The effectiveness of the antagonist was increased to 80% protection by coadministration with either an antihistamine or a 5-lipoxygenase inhibitor, agents which were separately insignificant in blocking the response to antigen. These results suggest a therapeutic utility for ABT-491, perhaps in combination with other anti-inflammatory agents, in the treatment of allergic rhinitis.


Subject(s)
Hypersensitivity/drug therapy , Imidazoles/pharmacology , Indoles/pharmacology , Platelet Activating Factor/antagonists & inhibitors , Rhinitis/drug therapy , Airway Resistance/drug effects , Animals , Capillary Permeability/drug effects , Guinea Pigs , Male , Platelet Activating Factor/physiology , Rats , Rats, Inbred BN
18.
J Med Chem ; 41(1): 74-95, 1998 Jan 01.
Article in English | MEDLINE | ID: mdl-9438024

ABSTRACT

Studies conducted with the goal of discovering a second-generation platelet-activating factor (PAF) antagonist have identified a novel class of potent and orally active antagonists which have high aqueous solubility and long duration of action in animal models. The compounds arose from the combination of the lipophilic indole portion of Abbott's first-generation PAF antagonist ABT-299 (2) with the methylimidazopyridine heterocycle moiety of British Biotechnology's BB-882 (1) and possess the positive attributes of both of these clinical candidates. Structure-activity relationship (SAR) studies indicated that modification of the indole and benzoyl spacer of lead compound 7b gave analogues that were more potent, longer-lived, and bioavailable and resulted in the identification of 1-(N, N-dimethylcarbamoyl)-4-ethynyl-3-[3-fluoro-4-[(1H-2-methylimidazo[4,5-c] pyrid-1-yl)methyl]benzoyl]indole hydrochloride (ABT-491, 22 m.HCl) which has been evaluated extensively and is currently in clinical development.


Subject(s)
Imidazoles/chemical synthesis , Platelet Activating Factor/antagonists & inhibitors , Platelet Aggregation Inhibitors/chemical synthesis , Platelet Membrane Glycoproteins/metabolism , Pyridines/chemical synthesis , Receptors, Cell Surface , Receptors, G-Protein-Coupled , Animals , Biological Availability , Blood Platelets/drug effects , Blood Platelets/physiology , Capillary Permeability/drug effects , Dogs , Female , Guinea Pigs , Humans , Imidazoles/chemistry , Imidazoles/pharmacology , Macaca fascicularis , Male , Molecular Structure , Platelet Activating Factor/pharmacology , Platelet Aggregation Inhibitors/chemistry , Platelet Aggregation Inhibitors/pharmacokinetics , Platelet Aggregation Inhibitors/pharmacology , Pyridines/chemistry , Pyridines/pharmacokinetics , Pyridines/pharmacology , Rats , Rats, Sprague-Dawley , Structure-Activity Relationship
19.
Bioorg Med Chem Lett ; 8(12): 1443-8, 1998 Jun 16.
Article in English | MEDLINE | ID: mdl-9873367

ABSTRACT

A series of P1 C alpha gem-disubstituted succinamide hydroxamate matrix metalloproteinase inhibitors were prepared stereoselectively and evaluated in vitro for their ability to inhibit MMP-1, MMP-2, and MMP-3. It was found that while methyl/allyl substitution as in 2 and 18 provided compounds that were broad spectrum inhibitors and nearly equipotent with parent inhibitor 1, a larger group such as bis-allyl as in 13 or gem-cyclopentyl as in 14 significantly reduced enzyme inhibition.


Subject(s)
Hydroxamic Acids/pharmacology , Metalloendopeptidases/antagonists & inhibitors , Protease Inhibitors/pharmacology , Animals , Hydroxamic Acids/chemistry , Hydroxamic Acids/pharmacokinetics , Models, Molecular , Molecular Structure , Protease Inhibitors/chemistry , Protease Inhibitors/pharmacokinetics , Rats
20.
Bioorg Med Chem Lett ; 8(16): 2087-92, 1998 Aug 18.
Article in English | MEDLINE | ID: mdl-9873491

ABSTRACT

A series of succinate-derived hydroxamic acids incorporating a macrocyclic ring were designed, synthesized, and evaluated as inhibitors of matrix metalloproteinases. The inhibitors were designed based on the published X-ray crystal structure of batimastat (1) complexed with human neutrophil collagenase (MMP-8). The synthesized compounds were shown to inhibit selected MMPs in vitro with low nanomolar potency.


Subject(s)
Collagenases/chemistry , Hydroxamic Acids/chemical synthesis , Matrix Metalloproteinase Inhibitors , Phenylalanine/analogs & derivatives , Protease Inhibitors/chemical synthesis , Thiophenes/chemistry , Thiophenes/chemical synthesis , Crystallography, X-Ray , Drug Design , Humans , Hydroxamic Acids/chemistry , Hydroxamic Acids/pharmacology , Indicators and Reagents , Kinetics , Matrix Metalloproteinase 8 , Models, Molecular , Phenylalanine/chemistry , Phenylalanine/pharmacology , Protease Inhibitors/chemistry , Protease Inhibitors/pharmacology , Structure-Activity Relationship , Succinates/chemical synthesis , Succinates/chemistry , Succinates/pharmacology , Thiophenes/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...